XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows From Operating Activities:    
Net loss $ (8,916) $ (9,746)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,787 1,669
Amortization of debt discount 496 60
Unrealized gain on investments in equity securities 156 (337)
Realized loss on investments in equity securities 0 805
Realized loss (gain) on available-for-sale debt securities 85 (17)
Stock-based compensation expense 7,015 3,922
Loss on disposal of property and equipment 113 121
Provision for bad debt 215 34
Changes in operating assets and liabilities:    
Accounts receivable (5,590) 25
Inventories (1,138) (64)
Prepaid expenses and other current assets (512) 205
Deposits 230 (98)
Change in operating lease right-of-use assets and lease liabilities 220 13
Accounts payable and other accrued expenses (4,983) 3,150
Accrued compensation and related expenses (661) (51)
Deferred revenue 14 (37)
Deferred tax liability 105 36
Net cash used in operating activities (3,364) (310)
Cash Flows From Investing Activities:    
Purchases of property and equipment (6,705) (2,542)
Software development costs (449) 0
Purchases of short-term investments (241,993) (136,252)
Sales/maturities of short-term investments 8,000 19,279
Acquisition of CTSA and F-airGate (5,019) 0
Patent and trademark costs (109) (75)
Net cash used in investing activities (246,275) (119,590)
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options and warrants 3,483 5,894
Proceeds from the issuance of convertible senior notes 0 115,000
Proceeds from public offering, net of $17.7 million in offering costs 269,825 0
Payment of deferred financing costs 0 (3,871)
Repayment of finance lease liabilities (32) (32)
Net cash provided by financing activities 273,276 116,991
Effect of exchange rate changes on cash and cash equivalents (153) 0
Net change in cash and cash equivalents 23,484 (2,909)
Cash and cash equivalents - beginning of year 36,873 47,235
Cash and cash equivalents - end of year 60,357 44,326
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Conversion of Series C Preferred Stock to common stock 765 0
Cost of Series C Preferred stock conversion included in additional paid-in-capital and accounts payable and accrued liabilities 1,800 0
CRYOPDP goodwill adjustment included in deferred tax liability 877 0
CRYOPDP goodwill adjustment included in fixed assets 71 0
MVE estimated working capital included in goodwill and accounts payable 500 0
Note valuation adjustment included in note payable and goodwill 275 0
Net unrealized (loss)/gain on available-for-sale debt securities (1,178) 336
Reclassification of realized (loss)/gain on available-for-sale debt securities to earnings (38) 27
Purchase of equipment through capital lease obligations 0 205
Fixed assets included in accounts payable and accrued liabilities 3,868 649
Convertible debt costs included in accounts payable and accrued liabilities $ 0 $ 212